The Health Resources and Services Administration issued a stern warning to Johnson & Johnson on Sept. 17, stating the company's plans to impose 340B rebates on certain drugs are in violation of federal law.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,